Global Patient Engagement Atlantis Health is a global player with offices in the United States, United Kingdom, Germany, Australia and New Zealand and a track record of delivering patient engagement programs across 30+ countries, indicating a broad geographic footprint and potential for multinational deployments.

Therapy Adherence Focus The company specializes in improving adherence, activation and initiation across the patient journey, including rarity and chronic therapy areas, suggesting opportunities to upsell comprehensive adherence programs, real-world evidence, and behavioral science-driven engagement for pharma portfolios facing persistence challenges.

Scale and Capabilities With 25+ years of experience and >200 programs across therapy areas, Atlantis Health can support large scale initiatives, including global launch support, disease-area-specific strategies, and cross-market patient education platforms for complex treatment regimens.

Digital & Data Readiness Current tech stack includes iCIMS, OneTrust, HubSpot, Microsoft 365 and analytics tooling, indicating readiness for CRM, privacy compliance, marketing automation, and data-driven insights to optimize patient engagement and measurement outcomes.

Growth Footprint & Revenue Recent revenue signals of mid-market scale (reported around 25.6 million in late 2025) and a funding base, combined with a robust historical impact in pharma and healthcare, point to opportunities for expanding service lines such as patient access programs, rare disease support research, and payer/health system partnerships.